SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-00-049564
Filing Date
2000-11-14
Accepted
2000-11-14 00:00:00
Documents
4
Period of Report
2000-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2030641z10-q.txt 10-Q 49556
2 EXHIBIT 10.38 a2030641zex-10_38.txt EX-10.38 170347
3 EXHIBIT 27 a2030641zex-27.txt EX-27 2067
4 EXHIBIT 99.1 a2030641zex-99_1.txt EX-99.1 33393
  Complete submission text file 0000912057-00-049564.txt   257126
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 764026
SIC: 2836 Biological Products, (No Diagnostic Substances)